University Of Michigan Rogel Cancer Center
Clinical trials sponsored by University Of Michigan Rogel Cancer Center, explained in plain language.
-
New hope for rare cancer: experimental drug targets tumor defense
Disease control OngoingThis study is testing a new oral drug called APG-115 for people with a specific type of advanced salivary gland cancer. The main goals are to find a safe and effective dose and to see if the drug can shrink tumors. It involves 41 participants whose cancer has a normal p53 gene an…
Phase: PHASE1, PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug duo aims to fight Tough-to-Treat prostate cancer
Disease control OngoingThis study is testing whether a combination of two drugs, olaparib and AZD6738, can help control advanced prostate cancer that has spread and no longer responds to standard hormone treatments. It will involve about 49 men to see how well the drugs work together and how safe they …
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug combo tested for Tough-to-Treat prostate cancer
Disease control OngoingThis study is testing whether a combination of two drugs, pembrolizumab and lenvatinib, can help control an aggressive form of prostate cancer that has spread. It is for men whose cancer has developed neuroendocrine features and has stopped responding to standard hormone therapie…
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for Tough-to-Treat leukemia: experimental drug combo enters testing
Disease control TerminatedThis study is testing whether adding a drug called venetoclax to a standard chemotherapy regimen (FLAG or CLAG) is more effective for treating newly diagnosed secondary acute myeloid leukemia (sAML). The main goal is to see if this combination helps more patients achieve complete…
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Could some breast cancer patients safely skip radiation?
Disease control OngoingThis study is testing whether certain breast cancer patients can safely skip radiation treatment after lumpectomy surgery. It focuses on postmenopausal women with specific low-risk tumor types who are taking hormone-blocking medication. The goal is to collect data showing these p…
Phase: NA • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Targeted radiation blitz aims to outsmart deadly brain cancer
Disease control OngoingThis study is testing a new, more precise way to deliver radiation therapy to people newly diagnosed with glioblastoma, a fast-growing brain tumor. Doctors will use advanced MRI scans during treatment to target higher radiation doses specifically to the most resistant parts of th…
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New drug hope to stop dangerous transplant complication in kids
Disease control OngoingThis study is testing if adding a drug called vorinostat to standard medications can better prevent graft-versus-host disease (GVHD) in children and young adults getting a bone marrow transplant for blood cancers. GVHD is a serious complication where the donor's immune cells atta…
Phase: PHASE1, PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New combo attack on spreading prostate cancer shows promise
Disease control OngoingThis study is testing a combination treatment for men whose prostate cancer has spread to only a few other places in the body. Doctors are using targeted radiation on the cancer spots along with a short, intense course of hormone therapy and a targeted drug. The main goal is to s…
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Can music be medicine? virtual sessions aim to soothe anxiety in young cancer survivors
Symptom relief OngoingThis study is testing whether a virtual, 8-week music relaxation program can help reduce anxiety in teens and young adults who have finished cancer treatment. Researchers are enrolling 50 participants aged 15-39 who report significant anxiety. The main goal is to see if this type…
Phase: NA • Sponsor: University of Michigan Rogel Cancer Center • Aim: Symptom relief
Last updated Mar 30, 2026 14:33 UTC